Cardima completes atrial fibrillation study:
This article was originally published in Clinica
Cardima, a US developer of microcatheter systems for diagnosing and treating abnormal heart rhythms, has completed a feasibility study of a device for treating atrial fibrillation. The ten-patient study took place at three US hospitals and the Fremont, California-based company plans to submit the results to the FDA by the end of the year to expand the trial to ten US centres. The device is already CE-marked in Europe.